Evidence map›Paper›PMID 27484460›Full record

ArticleImmunogenetics2017

Preferred SLA class I/class II haplotype combinations in German Landrace pigs.

Ulrike Gimsa, Chak-Sum Ho, Sabine E Hammer

Abstract read
PubMed Publisher
In one paragraph

Article in Immunogenetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Immunopeptidomics ofBiology · 2024
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 3 countries.

Ulrike GimsaInstitute of Behavioural Physiology, Leibniz Institute for Farm Animal Biology, Wilhelm-Stahl-Allee 2, 18196, Dummerstorf, Germany. gimsa@fbn-dummerstorf.de.
Chak-Sum HoGift of Life Michigan, 3861 Research Park Drive, Ann Arbor, MI, 48108-2217, USA.
Sabine E HammerDepartment of Pathobiology, Institute of Immunology, University of Veterinary Medicine, Veterinaerplatz 1, A-1210, Vienna, Austria.
Gift of Life Michigan · USResearch Institute for Farm Animal Biology (FBN) · DEUniversity of Veterinary Medicine Vienna · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Major histocompatibility complex (MHC) molecules are responsible for the antigen presentation to T lymphocytes. High recombination rates in the MHC genes, as observed in humans, are believed to serve the evolutionary goal to achieve a high genetic diversity, allowing for a broad and efficient immune response. In a cohort of 155 pedigreed German Landrace pigs (65 founders and 90 piglets), we found that MHC genes occur in particular class I and class II haplotype combinations. This phenomenon has not been described before, probably because most of the earlier MHC studies in pigs were not pedigree-based. After comparing our data with published genotypes of different European pig breeds and Asian pigs, we hypothesise that the combination of particular but different haplotypes in different geographical regions may have developed under the evolutionary pressure of regionally endemic pathogens. This proposed mechanism ensures an efficient immune response despite low recombination rates.

Indexed as

AnimalsBreedingFemaleGene FrequencyGenetic VariationGermanyHaplotypesHistocompatibility Antigens Class IHistocompatibility Antigens Class IIMalePolymerase Chain ReactionSequence Analysis, DNASus scrofaHistocompatibility Antigens Class IHistocompatibility Antigens Class IIPolymorphismSequence-specific primers PCRSLASus scrofaSwine leukocyte antigen

Identifiers

PMID27484460
OpenAlexW2478124390

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.